Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
Go back to Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 296.77 +5.75 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.02 | 52 Week High | $141.32 | |||
| Open | $292.12 | 52 Week Low | $97.79 | |||
| Day High | $298.58 | P/E | 47.48 | |||
| Day Low | $290.22 | EPS | $6.25 | |||
| Volume | 916,281 | |||||
